A detailed history of Evolution Advisers, Inc. transactions in Baxter International Inc stock. As of the latest transaction made, Evolution Advisers, Inc. holds 100 shares of BAX stock, worth $3,321. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$3,321
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

BUY
$74.57 - $87.19 $7,456 - $8,719
100 New
100 $8,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Evolution Advisers, Inc. Portfolio

Follow Evolution Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evolution Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Evolution Advisers, Inc. with notifications on news.